申请人:Novo Nordisk A/S
公开号:EP2444397A1
公开(公告)日:2012-04-25
This invention relates to compounds that are activators of glucokinase and thus may be useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial.
本发明涉及的化合物是葡萄糖激酶的激活剂,因此可用于控制、治疗、控制或辅助治疗对提高葡萄糖激酶活性有益的疾病。